The Pharmacy Council of India (PCI) has initiated the approval process for the existing pharmacy institutions for the academic session 2023-24 by opening its portal to apply for continuation of approval, introduction of new courses, raise in admission in the pharmacy courses along with various other services. The institutions which are looking for these approvals may have to apply within a time limit till February 20, 2023, as the last date for applying will not be extended under any circumstances, said the Council.
For those who are looking for approval for new institutions, the Council may come up with an announcement separately.
The PCI has opened the portal from February 3, 2023 for the institutions to submit applications for the Diploma in Pharmacy (D Pharm) course, Bachelor of Pharmacy (B Pharm) course, and the Master of Pharmacy (M Pharm) course, under the Schemes framed under the relevant Acts.
The institutions who want to change the name of institution or trust, change the address or location of the institution, change the examining authority, hospital, or close down the course of the institution, have to apply within the format during the timeframe.
During approval process for the academic year 2023-24, for introduction of new pharmacy courses by existing institutions, the institution will have to apply on the portal along with requisite Pharmacy Education Regulatory Charges (non-refundable) along with Goods and Services Tax (GST) and submit certain documents mandatorily at the time of application for consideration of the application.
For the B Pharm course, a consent of affiliation of examining authority and a No Objection Certificate of the State government should be submitted. In case the State Government has done away with the issuance of NOC of the State Government for starting of pharmacy course, in that case the institution shall upload the said communication from the state government as a documentary evidence.
For D.Pharm, Pharm.D and Pharm.D (Post Baccalaureate) or new M. Pharm course and introduction of new M Pharm specialisation or B Pharm (Practice) course, the institutions need to upload consent of affiliation of the Examining Authority and MoU with 300 bedded hospital (applicable for Pharm D course) in the prescribed format.
For raise of admissions, admissions are restricted to 60 seats for D.Pharm Course, 60 to 100 for B Pharm course, 15 per specialisation for M Pharm course, 30 for Pharm D course, 10 for Pharm D (PB) course and 40 for B Pharm (Practice) course. The institutions shall apply for raise in seats as per the provisions of the regulations and should conduct admissions only after the approval of the PCI and the examining authority, it said.
All institutions that are already approved by the PCI for conduct of course and approved under Section 12 for registration as a pharmacist for the pharmacy courses, have to mandatorily apply on the PCI portal, submitting all the requisite information and Pharmacy Education Regulatory Charges for consideration of approval.
Institutions already having approval for 2023-24 or beyond 2023-24 academic sessions shall also mandatorily apply in Standard Inspection Format (SIF) and pay the mandatory charges for retention of already granted approval, it added.
“Applying for approval is entirely the responsibility of the institutions and failure to apply will result in not being reflected in the approved list of Institutions on the Council’s website leading to ‘No Admission Year’,” said the statutory body.
|